Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Godrej Consumer Products delivered a strong Q3 FY26 with consolidated revenue growth of 9% and EBITDA expansion of 16%, driven by India business volume growth of 9% and margin improvement to 24.8%.
✓ Verified against BSE filing
Godrej Consumer Products delivered a strong Q3 FY26 with consolidated revenue growth of 9% and EBITDA expansion of 16%, driven by India business volume growth of 9% and margin improvement to 24.8%. Key drivers included cost savings from media and supply chain, favorable input costs, and strong performance in home care (air fresheners, fabric care) and personal care recovery post-GST reduction. International business showed resilience: Indonesia stabilized with 5% volume growth, while Africa/USA/Middle East grew 19% in INR terms. Management expects India EBITDA margins to sustain in the 24-26% range and aims for gradual volume growth improvement to 7-8% over 18-24 months. Risk: sharp oil price increases could pressure margins temporarily.
गोदरेज कंज्यूमर प्रोडक्ट्स ने तीसरी तिमाही में अच्छा प्रदर्शन किया। कंपनी की कुल कमाई 9% बढ़ी और मुनाफा (EBITDA) 16% बढ़ा। भारत में बिक्री की मात्रा 9% बढ़ी और मुनाफा मार्जिन 24.8% हो गया। इसकी वजह विज्ञापन और आपूर्ति में बचत, कम लागत और घरेलू सामान (एयर फ्रेशनर, कपड़े की देखभाल) की मजबूत बिक्री रही। जीएसटी कम होने से व्यक्तिगत देखभाल उत्पादों की बिक्री भी बढ़ी। अंतरराष्ट्रीय बाजार में इंडोनेशिया में 5% और अफ्रीका-अमेरिका-मिडिल ईस्ट में 19% बढ़ोतरी हुई। कंपनी को उम्मीद है कि भारत में मुनाफा मार्जिन 24-26% रहेगा और अगले 18-24 महीनों में बिक्री वृद्धि 7-8% तक पहुंच जाएगी। खतरा: तेल की कीमतें बढ़ने से मुनाफा कम हो सकता है।
0 delivered, 0 close, 1 missed.
View Promises →Sharp oil price increase could pressure margins
View Risks →Full transcript text is available on this route.
Read Transcript →India standalone business delivered high single-digit volume growth of 9% in Q3 FY26.
Indonesia business delivered stable underlying volume growth of 5% led by shampoo, hair color, baby care.
Africa, USA and Middle East business delivered outstanding sales growth of 19% in INR terms.
India standalone EBITDA margins stood at 24.8%, supported by cost savings and favorable input costs.
Management aims to gradually improve India volume growth from current 6-7% to 7-8% over the next 18-24 months.
Management expects Indonesia business recovery to begin meaningfully from FY27 as market conditions normalize.
Management expects the Africa/USA/Middle East business to deliver double-digit revenue and profit growth for the full year.
Management expects India EBITDA margins to remain in the 24-26% range annually, with quarterly fluctuations.
Management expects high single-digit underlying volume growth in India for the full year, driven by recovery in soaps and continued momentum in other categories.
The company targets high single-digit revenue growth at consolidated level for FY26, with stronger H2 trajectory.
India standalone and GAUM businesses are expected to deliver double-digit EBITDA growth for the full year.
Management noted that a sharp increase in oil prices (>15%) could temporarily impact margins, as they would not cut advertising to compensate.
While the peak of competitive intensity is behind, pricing pressures in Indonesia continue, and recovery is expected only from FY27.
Management admitted that the pet food test market in Tamil Nadu has yielded mixed results with lower-than-hoped market share, indicating product-market fit issues.
Management confirmed that legal expenses related to a class action suit are likely to continue for a few quarters, impacting other expenses.
Indonesia faces continued macroeconomic slowdown and pricing pressure, with volume growth expected to remain in low single digits for several quarters.
Africa's margins are subject to structural currency volatility, which could impact the mid-teens margin target.
A colder winter due to La Niña could reduce mosquito season, negatively impacting H2 sales of household insecticides.
Analyst questioned whether Mustache can scale beyond tier 2/3 online channels; management acknowledged uncertainty but cited expansion opportunities.
Mentioned in Q1 FY26, Q2 FY26
The company targets high single-digit revenue growth at consolidated level for FY26, with stronger H2 trajectory.
Mentioned in Q1 FY26, Q2 FY26
Management expects high single-digit underlying volume growth in India for the full year, driven by recovery in soaps and continued momentum in other categories.
Management expects India EBITDA margins to remain in the 24-26% range annually, with quarterly fluctuations.
Management noted that a sharp increase in oil prices (>15%) could temporarily impact margins, as they would not cut advertising to compensate.
View Risks →